Guerbet announces U.S. Food and Drug Administration (FDA) approval of Elucirem™ (Gadopiclenol)

Guerbet announces U.S. Food and Drug Administration (FDA) approval of Elucirem™ (Gadopiclenol)

Read the press release
ECR 2022Explore our innovations and step into the future, together.July 13th to 17thVienna (Wien)

ECR 2022
Explore our innovations and step into the future, together.

July 13th to 17th
Vienna (Wien)

Lear more
Innovation4MRI.com

Innovation4MRI.com

To all MRI enthusiasts, check out our new website Innovation4MRI.com

It includes summaries of recent research findings, infographics and video interviews with leading academic as well as industry experts.

Discover the website
Gadolinium Based Contrast Agents use and environment: current and future trends

ECR 2022 Symposium

Gadolinium Based Contrast Agents use and environment: current and future trends

Watch on-demand
Shutterstock 1566865627

Welcome to Guerbet Belgium

Nearly a century of passion and dedication

Guerbet has become one of the leading experts in medical imaging worldwide. Collectively, we offer a full range of medical solutions and services in diagnostic imaging and interventional imaging.

Learn more about Guerbet Belgium 

Discover the latest news of Guerbet

Latest news

993B21a6 8Beb 4E99 Bcf7 1Be4f3927bab

Guerbet shows its commitment to healthcare professionals with two ranges of consumables selected for their injection solutions

Read the press release